Diagnosis and management of congenital dyserythropoietic anemias

References

• Iolascon A, Russo R, Esposito MR, et al. Congenital dyserythropoietic anaemias: new acquisitions. Blood Transfus. 2011;9:278–280.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Heimpel H, Wahlin A, et al. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood. 2013;122:2162–2166.
   PubMed Web of Science ®Google Scholar
• Heimpel H, Matuschek A, Ahmed M, et al. Frequency of congenital dyserythropoietic anemias in Europe. Eur J Haematol. 2010;85:20–25.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Esposito MR, Russo R. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach. Haematologica. 2012;97:1786–1794.
   PubMed Web of Science ®Google Scholar
• Tamary H, Offret H, Dgany O, et al. Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1). Eur J Haematol. 2008;80:271–274.
   PubMed Web of Science ®Google Scholar
• Russo R, Gambale A, Esposito MR, et al. Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population. Am J Hematol. 2011;86:727–732.
   PubMed Web of Science ®Google Scholar
• Russo R, Gambale A, Langella C, et al. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores. Am J Hematol. 2014;89:E169E175.
   Web of Science ®Google Scholar
• Heimpel H, Iolascon A. Congenital dyserythropoietic anaemias ESH Handbook on Disorders of Iron Metabolism (IRON2009) [Internet]. 2009. [cited 2009 Dec 4]. Available from: http://www.esh.org/esh-handbook-on-disorders-of-iron-metabolism-2009/
   Google Scholar
• Chirnomas SD, Kupfer GM. The inherited bone marrow failure syndromes. PediatrClin North Am. 2013;60:1291–1310.
   PubMed Web of Science ®Google Scholar
• Fargo H, Christian P, Kratz N, et al. Erythrocyte adenosine deaminase: diagnostic value for diamond-blackfan anaemia. Br J Haematol. 2013 Feb;160(4):547–554. DOI:10.1111/bjh.12167.
   PubMed Web of Science ®Google Scholar
• King MJ, Garçon L, Hoyer JD, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;304–325. DOI:10.1111/ijlh.12335.
   PubMed Web of Science ®Google Scholar
• Iolascon A, De Falco L, Borgese F, et al. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis. Haematologica. 2009;94:1049–1059.
   PubMed Web of Science ®Google Scholar
• Heimpel H, Schwarz K, Ebnöther M, et al. Congenital dyserythropoietic anemia type I(CDA I): molecular genetics, clinical appearance, and prognosis based on longterm observation. Blood. 2006;107:334–340.
   PubMed Web of Science ®Google Scholar
• Shalev H, Kapleushnik Y, Haeskelzon L, et al. Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in young adults. Eur J Haematol. 2002;68:170–174.
   PubMed Web of Science ®Google Scholar
• Tamary H, Dgany O, Proust A, et al. Clinical and molecular variability in congenital dyserythropoietic anaemia type I. Br J Haematol. 2005;130:628–634.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Russo R, Delaunay J. Congenital dyserythropoietic anemias. CurrOpinHematol. 2011;18:146–151.
   Google Scholar
• El-Sheikh AA, Hashem H, Holman C, et al. Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension with pigeon chest deformity. Pediatr Blood Cancer. 2014;61:1460–1462.
   PubMed Web of Science ®Google Scholar
• Facon T, Mannessier L, Lepelley P, et al. Congenital dyserythropoietic anemia type I. Report on monozygotic twins with associated hemochromatosis and short stature. Blut. 1990;61:248–250.
   PubMedGoogle Scholar
• Roberts E, Madhusudhana KC, Newsom R, et al. Blindness due to angioid streaks in congenital dyserythropoietic anaemia type I. Br J Haematol. 2006;133:456.
   PubMedGoogle Scholar
• Lin SM, Chen M, Ma ES, et al. Intrauterine therapy in a fetus with congenital dyserythropoietic anaemia type I. J ObstetGynaecol. 2014;34:352–353.
   Google Scholar
• Shalev H, Avraham GP, Hershkovitz R, et al. Pregnancy outcome in congenital dyserythropoietic anemia type I. Eur J Haematol. 2008;81:317–321.
   PubMed Web of Science ®Google Scholar
• Landau D, Kapelushnik J, Harush MB, et al. Persistent pulmonary hypertension of the newborn associated with severe congenital anemia of various etiologies. J PediatrHematolOncol. 2015;37:60–62.
   PubMed Web of Science ®Google Scholar
• Heimpel H, Kellermann K, Neuschwander N, et al. The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells. Haematologica. 2010;95:1034–1036.
   PubMed Web of Science ®Google Scholar
• Dgany O, Avidan N, Delaunay J, et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet. 2002;71:1467–1474.
   PubMed Web of Science ®Google Scholar
• Noy-Lotan S, Dgany O, Lahmi R, et al. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated. Haematologica. 2009;94:629–637.
   PubMed Web of Science ®Google Scholar
• Ask K, Jasencakova Z, Menard P, et al. Codanin-1, mutated in the anaemic disease CDAI, regulates Asf1 function in S-phase histone supply. Embo J. 2012;31:2013–2023.
   PubMed Web of Science ®Google Scholar
• Renella R, Roberts NA, Brown JM, et al. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts. Blood. 2011;117:6928–6938.
   PubMed Web of Science ®Google Scholar
• Ahmed MR, Zaki M, Sabry MA, et al. Evidence of genetic heterogeneity in congenital dyserythropoietic anaemia type I. Br J Haematol. 2006;133:444–445.
   PubMed Web of Science ®Google Scholar
• Babbs C, Roberts NA, Sanchez-Pulido L, et al. Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I. Haematologica. 2013;98:1383–1387.
   PubMed Web of Science ®Google Scholar
• Alloisio N, Texier P, Denoroy L, et al. The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood. 1996;87:4433–4439.
   PubMed Web of Science ®Google Scholar
• De Franceschi L, Turrini F, del Giudice EM, et al. Decreased band 3 anion transport activity and band 3 clusterization in congenital dyserythropoietic anemia type II. ExpHematol. 1998;26:869–873.
   PubMed Web of Science ®Google Scholar
• Russo R, Esposito MR, Iolascon A. Inherited hematological disorders due to defects in coat protein (COP)II complex. Am J Hematol. 2013;88:135–140.
   PubMed Web of Science ®Google Scholar
• Schwarz K, Iolascon A, Verissimo F, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet. 2009;41:936–940.
   PubMed Web of Science ®Google Scholar
• Bianchi P, Fermo E, Vercellati C, et al. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. HumMutat. 2009;30:1292–1298.
   Google Scholar
• Singleton B, Bansal D, Varma N, et al. Homozygosity mapping reveals founder SEC23B-Y462C mutations in Indian congenital dyserythropoietic anemia type II. Clin Genet. 2015;88:195–197.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Russo R, Esposito MR, et al. Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship. Haematologica. 2010;95:708–715.
   PubMed Web of Science ®Google Scholar
• Skop AR, Liu H, Yates J, et al. Dissection of the mammalian midbody proteome reveals conserved cytokinesis mechanisms. Science. 2004;305(5680):61–66.
   PubMed Web of Science ®Google Scholar
• Satchwell TJ, Pellegrin S, Bianchi P, et al. Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis. Haematologica. 2013;98:1788–1796.
   PubMed Web of Science ®Google Scholar
• Tao J, Zhu M, Wang H, et al. SEC23B is required for the maintenance of murine professional secretory tissues. ProcNatlAcadSci U S A. 2012;109:E2001E2009.
   Google Scholar
• Khoriaty R, Vasievich MP, Jones M, et al. Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B. Mol Cell Biol. 2014;34:3721–3734.
   PubMed Web of Science ®Google Scholar
• Russo R, Langella C, Esposito MR, et al. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II. Blood Cells Mol Dis. 2013;51:17–21.
   PubMed Web of Science ®Google Scholar
• Sandström H, Wahlin A, Eriksson M, et al. Intravascular haemolysis and increased prevalence of myeloma and monoclonal gammopathy in congenital dyserythropoietic anaemia, type III. Eur J Haematol. 1994;52: 42–46.
   PubMed Web of Science ®Google Scholar
• Sandström H, Wahlin A. Congenital dyserythropoietic anemia type III. Haematologica. 2000;85:753–757.
   PubMed Web of Science ®Google Scholar
• Liljeholm M, Irvine AF, Vikberg AL, et al. Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. Blood. 2013;121:4791–4799.
   PubMed Web of Science ®Google Scholar
• Lind L, Sandström H, Wahlin A, et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet. 1995;4:109–112.
   PubMed Web of Science ®Google Scholar
• Carreno-Tarragona G, Trapiello-Valbuena F, Aranda-Salom J, et al. Antiphospholipid syndrome in a patient suffering from congenital dyserythropoietic anemia type III. Ann Hematol. 2015;94:1411–1412.
   PubMed Web of Science ®Google Scholar
• Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet. 2010;87:721–727.
   PubMed Web of Science ®Google Scholar
• Jaffray JA, Mitchell WB, Gnanapragasam MN, et al. Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm. Blood Cells Mol Dis. 2013;51:71–75.
   PubMed Web of Science ®Google Scholar
• Waye JS, Eng B. Krüppel-like factor 1: hematologic phenotypes associated with KLF1 gene mutations. Int J Lab Hematol. 2015;37(Suppl 1):78–84.
   PubMed Web of Science ®Google Scholar
• Siatecka M, Bieker JJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood. 2011;118:2044–2054.
   PubMed Web of Science ®Google Scholar
• Magor GW, Tallack MR, Gillinder KR, et al. KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome. Blood. 2015;125:2405–2417.
   PubMed Web of Science ®Google Scholar
• Gao J, Chen YH, Peterson LC. GATA family transcriptional factors: emerging suspects in hematologic disorders. ExpHematolOncol. 2015;4:28.
   Google Scholar
• Ciovacco WA, Raskind WH, Kacena MA. Human phenotypes associated with GATA-1 mutations. Gene. 2008;427:1–6.
   PubMed Web of Science ®Google Scholar
• Di Pierro E, Russo R, Karakas Z, et al. Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis. Eur J Haematol. 2015;94:491–497.
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Ghazvinian R, Do R, et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. JClin Invest. 2012;122:2439–2443.
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Ulirsch JC, Tchaikovskii V, et al. X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. JClin Invest. 2015;125:1665–1669.
   PubMed Web of Science ®Google Scholar
• Ferguson PJ, Chen S, Tayeh MK, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005;42:551–557.
   PubMed Web of Science ®Google Scholar
• Shteyer E, Saada A, Shaag A, et al. Exocrine pancreatic insufficient, dyserythropoietic anemia, and calvarial hyperostosis are caused by a mutation in COX412 gene. Am J Hum Genet. 2009;84:412–417.
   PubMed Web of Science ®Google Scholar
• Samkari A, Borzutzky A, Fermo E, et al. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia. Pediatrics. 2010;125:e964e968.
   Web of Science ®Google Scholar
• Kautz L, Nemeth E. Molecular liaisons between erythropoiesis and iron metabolism. Blood. 2014;124:479–482.
   PubMed Web of Science ®Google Scholar
• Tamary H, Shalev H, Perez-Avraham G, et al. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood. 2008;112:5241–5244.
   PubMed Web of Science ®Google Scholar
• Casanovas G, Swinkels DW, Altamura S, et al. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II. J Mol Med (Berl). 2011;89:811–816.
   PubMed Web of Science ®Google Scholar
• Shalev H, Perez-Avraham G, Kapelushnik J, et al. High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I. Eur J Haematol. 2013;90:31–36.
   PubMed Web of Science ®Google Scholar
• Kautz L, Jung G, Valore EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014;46:678684s.
   Web of Science ®Google Scholar
• Liu G, Niu S, Dong A, et al. A Chinese family carrying novel mutations in SEC23B and HFE2, the genes responsible for congenital dyserythropoietic anaemia II (CDA II) and primary iron overload, respectively. Br J Haematol. 2012;158:143–145.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Doisaki S, Okamoto A, et al. A case of congenital dyserythropoietic anemia type 1 in a Japanese adult with a CDAN1 gene mutation and an inappropriately low serum hepcidin-25 level. Intern Med. 2012;51(8):917–920.
   PubMed Web of Science ®Google Scholar
• Berdoukas V, Nord A, Carson S, et al. Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol. 2013;88:E283E285.
   Web of Science ®Google Scholar
• Parez N, Dommergues M, Zupan V, et al. Severe congenital dyserythropoietic anaemia type I: prenatal management, transfusion support and alpha-interferon therapy. Br J Haematol. 2000;110:420–423.
   PubMed Web of Science ®Google Scholar
• Fermo E, Bianchi P, Notarangelo LD, et al. CDAII presenting as hydrops foetalis: molecular characterization of two cases. Blood Cells Mol Dis. 2010;45:20–22.
   PubMed Web of Science ®Google Scholar
• Perrotta S, Del Giudice EM, Carbone R, et al. Gilbert’s syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II). J Pediatr. 2000;136:556–559.
   PubMed Web of Science ®Google Scholar
• Williams EJ, Green J, Beckingham I, et al. British Society of Gastroenterology. Guidelines on the management of common bile duct stones (CBDS). Gut. 2008;57:1004–1021.
   PubMed Web of Science ®Google Scholar
• Fracchia E, Elkababri M, Cantello C, et al. Venous-like leg ulcers without venous insufficiency in congenital anemia: successful treatment using compression bandages. Dermatol Surg. 2010;36:1336–1340.
   PubMed Web of Science ®Google Scholar
• Nair V, Das S, Sharma A. Hematopoietic stem cell transplantation in children with genetic defects. Indian Pediatr. 2009;46:241–243.
   PubMed Web of Science ®Google Scholar
• Ayas M, Al-Jefri A, Baothman A, et al. Transfusion-dependent congenital dyserythropoietic anemia type I successfully treated with allogeneic stem cell transplantation. Bone Marrow Transplant. 2002;29:681–682.
   PubMed Web of Science ®Google Scholar
• Unal S, Russo R, Gumruk F, et al. Successful hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia type II. Pediatr Transplant. 2014;18:E130E133.
   Web of Science ®Google Scholar
• Modi G, Shah S, Madabhavi I, et al. Successful allogeneic hematopoietic stem cell transplantation of a patient suffering from type II congenital dyserythropoietic anemia a rare case report from Western India. Case Rep Hematol. 2015;2015:792485.
   PubMedGoogle Scholar
• Lavabre-Bertrand T, Ramos J, Delfour C, et al. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I. Eur J Haematol. 2004;73:380–383.
   PubMed Web of Science ®Google Scholar
• Angelucci E, Barosi G, Camaschella C, et al. Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008;93:741–752.
   PubMed Web of Science ®Google Scholar
• Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci. 2010;1214:57–69.
   PubMed Web of Science ®Google Scholar
• Iolascon A, Andolfo I, Russo R. Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias. Haematologica. 2015;100:3–6.
   PubMed Web of Science ®Google Scholar